ABC分类法和PQ分析法在某肿瘤医院免疫增强剂合理用药中的应用

Application of activity based classification and price-quantity analysis in the rational use of immunopotentiator in a tumor hospital

目的:为免疫增强剂的分类管理及合理使用提供参考。方法:收集某院2016年免疫增强剂品种、用药数量及金额等数据,采用ABC分类法和PQ分析法对免疫增强剂的使用合理性进行分析。并抽取部分住院病历,对用药合理性进行分析。结果:共有35个品种的免疫增强剂被使用,ABC分类法结果 A、B、C类品种各占比29.7%、18.9%、51.4%,相应用药金额占比为77.744%、16.210%、6.046%,结构不够合理。PQ分析结果用量大、价格高的品种共4个,用量大、价格低的品种共10个,两类品种累积用药金额及用药总量构成分别为84.1%、89.4%。免疫增强剂使用医嘱共1 952份,其中不合理使用659份,占33.8%。结论:基于用药合理性和经济性,应加强部分品种的重点监管,并调整限制部分品种品规的使用。

OBJECTIVE To provide a reference for rational use of immunopotentiator in the clinical practice.METHODSThe theories of price-quantity（PQ）analysis and activity based classification（ABC）were utilized to analyze the average price,total usage amount,proportion of amount of immunopotentiator in 2016.Retrospective analysis was performed for inpatient medical records to analyze the rationality of the use of drugs.RESULTS Totally 35 immunopotentiators were used,class A,B,C drugs accounted for 29.7%,18.9% and 51.4%,respectively,the corresponding total medication doses accounted for77.744%,16.210% and 6.046%,with an unreasonable structure.The results of PQ analysis showed that there were 4 drugs with higher doses and prices,10 with high doses and lower prices,the accumulated price and dose of them were 84.1% and89.4%,respectively.There were 1952 prescriptions for immunopotentiators,of which 659 were used unreasonably,accounting for 33.8%.CONCLUSION Supervision should be enhanced for some drugs,some drugs and strengths should be limited.